Risk assessment: carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 in travellers previously hospitalised in Gran Canaria

17 July 2018

Article: 52/2806

A new risk assessment has been published by the European Centre for Disease Prevention and Control (ECDC) which evaluates the risk of transmission and further spread of OXA-48-producing Klebsiella pneumoniae ST392 from travellers, having sought medical care in Gran Canaria, to healthcare facilities in their country of origin in the EU/EEA. Between January and April 2018, Sweden and Norway reported a cluster of returning travellers who carried or were infected with carbapenemase (OXA-48)-producing Klebsiella pneumoniae ST392. All cases were associated with hospital admissions in Gran Canaria.

The risk for individual travellers to acquire OXA-48-producing K. pneumoniae ST392 of the Gran Canaria cluster without healthcare contact is very low. However, if carriers of the Gran Canaria cluster are admitted to a hospital in their country of origin there is a high risk of transmission and subsequent outbreaks if OXA-48-producing K. pneumoniae ST392 carriage remains undetected and there are no adequate infection control and prevention measures.

Source: ECDC, 11 July 2018